{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:45:14Z","timestamp":1786373114277,"version":"build-2736575974"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"abstract":"<jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>AKI is common in patients with cancer, and it causes interruptions in therapy and increased hospital length of stay, cost, and mortality. Although cancer patients are susceptible to all of the usual causes of AKI in patients without cancer, there are a number of AKI syndromes that occur more frequently or are unique to this patient population. AKI also confers substantially increased risk of short-term death, and the ability to reverse AKI portends a better outcome in some cancers, such as multiple myeloma. Several trends in oncology, including increased survival, better supportive care, older patients who have received multiple chemotherapy regimens, and new therapeutic options, are driving an increase in the numbers of cancer patients who develop AKI. As a result, nephrologists should be increasingly familiar with the diagnosis, management, and treatment of AKI in this setting. Here, we summarize recent data on epidemiology of AKI in cancer patients, describe the most common AKI syndromes in this population, and highlight emerging areas in the growing field of onconephrology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.03140312","type":"journal-article","created":{"date-parts":[[2012,8,11]],"date-time":"2012-08-11T20:25:39Z","timestamp":1344716739000},"page":"1692-1700","source":"Crossref","is-referenced-by-count":111,"title":["Onco-Nephrology"],"prefix":"10.2215","volume":"7","author":[{"given":"Albert Q.","family":"Lam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin D.","family":"Humphreys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-22-20230811","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.semnephrol.2010.09.001","article-title":"Onco-nephrology: Kidney disease in the cancer patient: Introduction","volume":"30","author":"Humphreys","year":"2010","journal-title":"Semin Nephrol"},{"key":"R3-22-20230811","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ejim.2011.05.005","article-title":"Incidence of acute kidney injury in cancer patients: A Danish population-based cohort study","volume":"22","author":"Christiansen","year":"2011","journal-title":"Eur J Intern Med"},{"key":"R4-22-20230811","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/j.1464-410X.2011.10629.x","article-title":"Targeted therapy for advanced renal cell cancer (RCC): A Cochrane systematic review of published randomised trials","volume":"108","author":"Coppin","year":"2011","journal-title":"BJU Int"},{"key":"R5-22-20230811","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","article-title":"Improved survival in multiple myeloma and the impact of novel therapies","volume":"111","author":"Kumar","year":"2008","journal-title":"Blood"},{"key":"R6-22-20230811","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1002\/cncr.25306","article-title":"Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome","volume":"116","author":"Lahoti","year":"2010","journal-title":"Cancer"},{"key":"R7-22-20230811","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1093\/ndt\/gfr094","article-title":"Post-operative acute kidney injury in patients with renal cell carcinoma is a potent risk factor for new-onset chronic kidney disease after radical nephrectomy","volume":"26","author":"Cho","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R8-22-20230811","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1470-2045(06)70803-8","article-title":"Chronic kidney disease after nephrectomy in patients with renal cortical tumours: A retrospective cohort study","volume":"7","author":"Huang","year":"2006","journal-title":"Lancet Oncol"},{"key":"R9-22-20230811","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.juro.2008.09.017","article-title":"Partial nephrectomy versus radical nephrectomy in patients with small renal tumors\u2014is there a difference in mortality and cardiovascular outcomes?","volume":"181","author":"Huang","year":"2009","journal-title":"J Urol"},{"key":"R10-22-20230811","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0090-4295(03)00773-8","article-title":"Practice patterns among urologic surgeons treating localized renal cell carcinoma in the laparoscopic age: Technology versus oncology","volume":"62","author":"Scherr","year":"2003","journal-title":"Urology"},{"key":"R11-22-20230811","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/cncr.23520","article-title":"Survival rates after resection for localized kidney cancer: 1989 to 2004","volume":"113","author":"Russo","year":"2008","journal-title":"Cancer"},{"key":"R12-22-20230811","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.juro.2009.10.002","article-title":"Unintended consequences of laparoscopic surgery on partial nephrectomy for kidney cancer","volume":"183","author":"Abouassaly","year":"2010","journal-title":"J Urol"},{"key":"R14-22-20230811","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/bmt.2011.46","article-title":"Acute kidney injury following HCT: Incidence, risk factors and outcome","volume":"46","author":"Lopes","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"R15-22-20230811","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3816\/CLM.2008.n.003","article-title":"A comparison of inpatient length of stay and costs among patients with hematologic malignancies (excluding Hodgkin disease) associated with and without acute renal failure","volume":"8","author":"Candrilli","year":"2008","journal-title":"Clin Lymphoma Myeloma"},{"key":"R16-22-20230811","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00134-007-0579-1","article-title":"Should dialysis be offered to cancer patients with acute kidney injury?","volume":"33","author":"Darmon","year":"2007","journal-title":"Intensive Care Med"},{"key":"R17-22-20230811","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.2215\/CJN.02130309","article-title":"Sustained low efficiency dialysis in the continuous mode (C-SLED): Dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients","volume":"4","author":"Salahudeen","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R18-22-20230811","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1200\/JCO.2006.05.7869","article-title":"Prognosis of critically ill patients with cancer and acute renal dysfunction","volume":"24","author":"Soares","year":"2006","journal-title":"J Clin Oncol"},{"key":"R19-22-20230811","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.2215\/CJN.02780312","article-title":"Onco-Nephrology: Renal Toxicities of Chemotherapeutic Agents","volume":"7","author":"Perazella","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R20-22-20230811","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMcp042806","article-title":"Clinical practice. Hypercalcemia associated with cancer","volume":"352","author":"Stewart","year":"2005","journal-title":"N Engl J Med"},{"key":"R21-22-20230811","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1053\/j.ajkd.2010.07.009","article-title":"The spectrum of kidney involvement in lymphoma: A case report and review of the literature","volume":"56","author":"Cohen","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"R22-22-20230811","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0002-9343(62)90289-9","article-title":"Renal lesions associated with malignant lymphomas","volume":"32","author":"Richmond","year":"1962","journal-title":"Am J Med"},{"key":"R23-22-20230811","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.ajkd.2003.08.004","article-title":"Lymphomas diagnosed by percutaneous kidney biopsy","volume":"42","author":"Tornroth","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R24-22-20230811","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1001\/archinte.1990.00040031693017","article-title":"Renal failure in multiple myeloma. Pathogenesis and prognostic implications","volume":"150","author":"Alexanian","year":"1990","journal-title":"Arch Intern Med"},{"key":"R25-22-20230811","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/archinte.158.17.1889","article-title":"Renal failure in multiple myeloma: Presenting features and predictors of outcome in 94 patients from a single institution","volume":"158","author":"Blad\u00e9","year":"1998","journal-title":"Arch Intern Med"},{"key":"R26-22-20230811","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/ndt\/13.6.1438","article-title":"Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies","volume":"13","author":"Montseny","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"R27-22-20230811","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nrneph.2011.168","article-title":"The pathogenesis and diagnosis of acute kidney injury in multiple myeloma","volume":"8","author":"Hutchison","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"R28-22-20230811","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1136\/jcp.2010.079236","article-title":"Differential progression of renal scarring and determinants of late renal recovery in sustained dialysis dependent acute kidney injury secondary to myeloma kidney","volume":"63","author":"Basnayake","year":"2010","journal-title":"J Clin Pathol"},{"key":"R29-22-20230811","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1681\/ASN.2010080857","article-title":"Early reduction of serum-free light chains associates with renal recovery in myeloma kidney","volume":"22","author":"Hutchison","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R30-22-20230811","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/archinte.1990.00390160111022","article-title":"Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy","volume":"150","author":"Johnson","year":"1990","journal-title":"Arch Intern Med"},{"key":"R31-22-20230811","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/ki.1988.127","article-title":"Controlled plasma exchange trial in acute renal failure due to multiple myeloma","volume":"33","author":"Zucchelli","year":"1988","journal-title":"Kidney Int"},{"key":"R32-22-20230811","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/0003-4819-143-11-200512060-00005","article-title":"Plasma exchange when myeloma presents as acute renal failure: A randomized, controlled trial","volume":"143","author":"Clark","year":"2005","journal-title":"Ann Intern Med"},{"key":"R33-22-20230811","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1056\/NEJMc1101834","article-title":"Renal improvement in myeloma with bortezomib plus plasma exchange","volume":"364","author":"Burnette","year":"2011","journal-title":"N Engl J Med"},{"key":"R34-22-20230811","first-page":"102","article-title":"Plasma exchange therapy in acute renal failure due to multiple myeloma","volume":"1","author":"Cagnoli","year":"1983","journal-title":"Life Support Syst"},{"key":"R35-22-20230811","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/0002-9343(79)91185-9","article-title":"Plasmapheresis in the treatment of acute renal failure in multiple myeloma","volume":"66","author":"Misiani","year":"1979","journal-title":"Am J Med"},{"key":"R36-22-20230811","first-page":"1","article-title":"Prognostic factors and effectiveness of treatment in acute renal failure due to multiple myeloma: A review of 50 cases","volume":"28","author":"Pozzi","year":"1987","journal-title":"Clin Nephrol"},{"key":"R37-22-20230811","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000013424","article-title":"Plasma exchange in rapidly progressive renal failure due to multiple myeloma. A retrospective case series","volume":"19","author":"Moist","year":"1999","journal-title":"Am J Nephrol"},{"key":"R38-22-20230811","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1542-4758.2010.00481.x","article-title":"Role of plasmapheresis in the management of myeloma kidney: A systematic review","volume":"14","author":"Gupta","year":"2010","journal-title":"Hemodial Int"},{"key":"R39-22-20230811","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2215\/CJN.04590908","article-title":"Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis","volume":"4","author":"Hutchison","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R40-22-20230811","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1542-4758.2011.00587.x","article-title":"Impact of free light chain hemodialysis in myeloma cast nephropathy: A case-control study","volume":"15","author":"Peters","year":"2011","journal-title":"Hemodial Int"},{"key":"R41-22-20230811","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2215\/CJN.03090906","article-title":"Light chains, casts, sheets and fibrils: Monoclonal immunoglobulin diseases and immunotactoid\/fibrillary glomerulopathy","volume":"1","author":"Dember","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R42-22-20230811","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.semnephrol.2010.09.004","article-title":"Ig-related renal disease in lymphoplasmacytic disorders: An update","volume":"30","author":"Ronco","year":"2010","journal-title":"Semin Nephrol"},{"key":"R43-22-20230811","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1056\/NEJMra0904569","article-title":"The tumor lysis syndrome","volume":"364","author":"Howard","year":"2011","journal-title":"N Engl J Med"},{"key":"R44-22-20230811","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/leu.2011.109","article-title":"Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol","volume":"25","author":"Blum","year":"2011","journal-title":"Leukemia"},{"key":"R45-22-20230811","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ki.1994.417","article-title":"Acute renal failure in the setting of bone marrow transplantation","volume":"46","author":"Zager","year":"1994","journal-title":"Kidney Int"},{"key":"R46-22-20230811","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1159\/000168889","article-title":"Acute renal failure in patients following bone marrow transplantation: Prevalence, risk factors and outcome","volume":"15","author":"Gruss","year":"1995","journal-title":"Am J Nephrol"},{"key":"R47-22-20230811","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1046\/j.1523-1755.2002.00455.x","article-title":"Renal dysfunction in allogeneic hematopoietic cell transplantation","volume":"62","author":"Parikh","year":"2002","journal-title":"Kidney Int"},{"key":"R48-22-20230811","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1053\/j.ajkd.2004.11.013","article-title":"Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation","volume":"45","author":"Parikh","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R49-22-20230811","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/sj.bmt.1705599","article-title":"Acute renal failure after allogeneic myeloablative stem cell transplantation: Retrospective analysis of incidence, risk factors and survival","volume":"39","author":"Kersting","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"R50-22-20230811","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1097\/01.ASN.0000129981.50357.1C","article-title":"Acute renal failure after nonmyeloablative hematopoietic cell transplantation","volume":"15","author":"Parikh","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R51-22-20230811","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/bmt.2009.99","article-title":"A multicenter, retrospective study of acute kidney injury in adult patients with nonmyeloablative hematopoietic SCT","volume":"45","author":"Liu","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"R52-22-20230811","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/ki.1996.405","article-title":"Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer","volume":"50","author":"Merouani","year":"1996","journal-title":"Kidney Int"},{"key":"R53-22-20230811","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1046\/j.1523-1755.2003.00936.x","article-title":"Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosis","volume":"63","author":"Fadia","year":"2003","journal-title":"Kidney Int"},{"key":"R54-22-20230811","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0272-6386(89)80054-X","article-title":"Acute renal failure following bone marrow transplantation: A retrospective study of 272 patients","volume":"13","author":"Zager","year":"1989","journal-title":"Am J Kidney Dis"},{"key":"R55-22-20230811","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/sj.ki.5000055","article-title":"Acute renal failure in hematopoietic cell transplantation","volume":"69","author":"Parikh","year":"2006","journal-title":"Kidney Int"},{"key":"R57-22-20230811","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann Intern Med"},{"key":"R58-22-20230811","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: Incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"R59-22-20230811","first-page":"3599","article-title":"Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: A prospective cohort study of the European Group for Blood and Marrow Transplantation","volume":"92","author":"Carreras","year":"1998","journal-title":"Blood"},{"key":"R60-22-20230811","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1002\/hep.23533","article-title":"Hepatobiliary complications of hematopoietic cell transplantation, 40 years on","volume":"51","author":"McDonald","year":"2010","journal-title":"Hepatology"},{"key":"R61-22-20230811","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bbmt.2010.02.009","article-title":"Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: A multicenter, randomized, dose-finding trial","volume":"16","author":"Richardson","year":"2010","journal-title":"Biol Blood Marrow Transplan"},{"key":"R62-22-20230811","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1537-2995.2004.00700.x","article-title":"Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: A diagnostic dilemma","volume":"44","author":"George","year":"2004","journal-title":"Transfusion"},{"key":"R63-22-20230811","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0360-3016(02)03793-8","article-title":"Successful treatment of radiation nephropathy with angiotensin II blockade","volume":"55","author":"Cohen","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R64-22-20230811","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1681\/ASN.2004100843","article-title":"Renal failure associated with cancer and its treatment: An update","volume":"16","author":"Humphreys","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R65-22-20230811","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","article-title":"Small vessels, big trouble in the kidneys and beyond: Hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"118","author":"Laskin","year":"2011","journal-title":"Blood"},{"key":"R66-22-20230811","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.bmt.1705454","article-title":"Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease","volume":"38","author":"Wolff","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"R67-22-20230811","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2165\/00003495-200969020-00004","article-title":"Thrombotic microangiopathy in haematopoietic stem cell transplantation: Diagnosis and treatment","volume":"69","author":"Choi","year":"2009","journal-title":"Drugs"},{"key":"R68-22-20230811","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2215\/CJN.00380705","article-title":"Nephrotic syndrome after hematopoietic cell transplantation: Do glomerular lesions represent renal graft-versus-host disease?","volume":"1","author":"Brukamp","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R69-22-20230811","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1053\/j.ackd.2011.02.006","article-title":"High cut-off dialysis membranes: Current uses and future potential","volume":"18","author":"Gondouin","year":"2011","journal-title":"Adv Chronic Kidney Dis"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201210000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:42:26Z","timestamp":1786369346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201210000-00022"}},"subtitle":["AKI in the Cancer Patient"],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":66,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.03140312","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}